郑青平, 陈龙华, 吴德华. 原发性肝癌三维适形放射治疗和介入治疗加放疗的疗效比较[J]. 中国肿瘤临床, 2005, 32(21): 1239-1241.
引用本文: 郑青平, 陈龙华, 吴德华. 原发性肝癌三维适形放射治疗和介入治疗加放疗的疗效比较[J]. 中国肿瘤临床, 2005, 32(21): 1239-1241.
Zheng Qingping, Chen Longhua, Wu Dehua. The Comparison of the Efficacy between Three Dimensional Conformal Radiotherapy (3DCRT) alone and Transcatheter Arterial Chemoembolization (TACE) plus 3DCRT for Treatment of Unresectable Hepatacelluar Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(21): 1239-1241.
Citation: Zheng Qingping, Chen Longhua, Wu Dehua. The Comparison of the Efficacy between Three Dimensional Conformal Radiotherapy (3DCRT) alone and Transcatheter Arterial Chemoembolization (TACE) plus 3DCRT for Treatment of Unresectable Hepatacelluar Carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 32(21): 1239-1241.

原发性肝癌三维适形放射治疗和介入治疗加放疗的疗效比较

The Comparison of the Efficacy between Three Dimensional Conformal Radiotherapy (3DCRT) alone and Transcatheter Arterial Chemoembolization (TACE) plus 3DCRT for Treatment of Unresectable Hepatacelluar Carcinoma

  • 摘要: 目的: 评价单纯三维适形放射治疗(3DCRT)与经皮肝动脉化疗栓塞术(TACE)结合3DCRT治疗不能手术的原发性肝癌(HCC)的疗效。 方法: 1999年1月至2001年10月,98例不能手术的HCC患者中,67例单纯3DCRT,31例TACE1~2次后3DCRT。放疗采用6MV射线,6Gy/次,隔日1次,总剂量54~60Gy;TACE采用超液态碘油、顺铂、吡喃阿霉素、丝裂霉素、明胶海绵颗粒经肝动脉化疗栓塞。 结果: 3DCRT组与3DCRT+TACE组近期有效率分别为83.6%、87.1%,1、2、3年生存率分别为89.6%、53.7%、22.4%和90.3%、51.6%、25.8%,两组差异无显著性(P0.05)。 结论: 3DCRT可作为非手术治疗HCC的有效方法之一。

     

    Abstract: Objective : To evaluate the therapeutic effects of three dimensional conformal radiation(3DCRT)and transcatheter arterial chemoembolization (TACE) combined with 3DCRT for the unresectable primary hepatacelluar carcinoma (HCC). Methods From January 1999 to October 2001, a total of 98 patients with HCC were treated. Sixty-seven of the 98 patients were treated with 3DCRT alone and 31 were treated with TACE plus 3DCRT. In the 3DCRT group, the total radiation dose 54~60Gy was given by 6MV X-ray, 6Gy each time and once every other day. In the 3DCRT+TACE group, TACE was given 1~2 times before 3DCRT.TACE was performed using lipiodol, cisplatin,perarubicin, mitomycin,followed by gelatin sponge cubes. Results : The efficacy rate for the 3DCRT group and the 3DCRT plus TACE group was 83.6% and 87.1%, respectively. The 1-, 2-, 3-year survival rate was 89.6%, 53.7% and 22.4%, and 90.3%, 51.6% and 25.8%, respectively. No significant difference for the efficacy rate or survival rate was found in the two groups (P0.05). Conclusion : The 3DCRT is effective and feasible and can be chosen as one of the first-line means in treating unresectable HCC.

     

/

返回文章
返回